Puma Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBYI and other ETFs, options, and stocks.About PBYI
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer.
CEOAlan H. Auerbach
CEOAlan H. Auerbach
Employees172
Employees172
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2010
Founded2010
Employees172
Employees172
PBYI Key Statistics
Market cap280.93M
Market cap280.93M
Price-Earnings ratio7.65
Price-Earnings ratio7.65
Dividend yield—
Dividend yield—
Average volume397.66K
Average volume397.66K
High today$5.67
High today$5.67
Low today$5.44
Low today$5.44
Open price$5.66
Open price$5.66
Volume214.54K
Volume214.54K
52 Week high$6.12
52 Week high$6.12
52 Week low$2.58
52 Week low$2.58
Stock Snapshot
With a market cap of 280.93M, Puma Biotechnology(PBYI) trades at $5.44. The stock has a price-to-earnings ratio of 7.65.
On 2025-12-17, Puma Biotechnology(PBYI) stock traded between a low of $5.44 and a high of $5.67. Shares are currently priced at $5.44, which is 0.0% above the low and -4.1% below the high.
The Puma Biotechnology(PBYI)'s current trading volume is 214.54K, compared to an average daily volume of 397.66K.
During the past year, Puma Biotechnology(PBYI) stock moved between $2.58 at its lowest and $6.12 at its peak.
During the past year, Puma Biotechnology(PBYI) stock moved between $2.58 at its lowest and $6.12 at its peak.
People also own
Based on the portfolios of people who own PBYI. This list is generated using Robinhood data, and it’s not a recommendation.